NCT05208502

Brief Summary

The bispectral index parameter is used to guide the titration of general anesthesia, however; conflicting results between different studies cannot prove the benefit of EEG monitor on improvement of OR efficiency. Next Generation SedLine features an enhanced signal processing engine, which provides processed EEG parameters. This four channel EEG monitor for the monitoring of perioperative anesthesia depth prevent overdose of medication and may help for individualized anesthetic plan. This research intended to observe the emergence time from end of the surgical wound closure to patient awake (or to extubation) with or without SedLine.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
126

participants targeted

Target at P50-P75 for all trials

Timeline
Completed

Started Feb 2022

Typical duration for all trials

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

June 4, 2020

Completed
1.6 years until next milestone

First Posted

Study publicly available on registry

January 26, 2022

Completed
27 days until next milestone

Study Start

First participant enrolled

February 22, 2022

Completed
2.9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 31, 2024

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2024

Completed
Last Updated

January 24, 2024

Status Verified

February 1, 2023

Enrollment Period

2.9 years

First QC Date

June 4, 2020

Last Update Submit

January 23, 2024

Conditions

Outcome Measures

Primary Outcomes (1)

  • DSA monitor group has less emergence time

    Patients with SedLine monitor may have shorter emergence time. The prolonged emergence rate is low with SedLine monitor.

    24 hours

Study Arms (2)

BIS

All inclusions will receive the general anesthesia with BIS monitor, a researcher who is not participated in the clinical practice will record the emergence characters and the EEG monitor signal. As the surgery ends, this researcher will record the time started from the end of the surgery to extubation, as well as the emergence quality when the patient was evaluated.

DSA

All inclusions will receive the general anesthesia with SedLine monitor, a researcher who is not participated in the clinical practice will record the emergence characters and the DSA monitor signal. As the surgery ends, this researcher will record the time started from the end of the surgery to extubation, as well as the emergence quality when the patient was evaluated.

Device: DSA monitor

Interventions

Next Generation SedLine features an enhanced signal processing engine, which provides processed EEG parameters. This four channel EEG monitor for the monitoring of perioperative anesthesia depth prevent overdose of medication and may help for individualized anesthetic plan

Also known as: the time when the inclusion started emergence to extubation will be recorded
DSA

Eligibility Criteria

Age20 Years - 70 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodProbability Sample
Study Population

patients who need routine general anesthesia

You may qualify if:

  • patients who need routine general anesthesia
  • have no neurological problem
  • have no dermo issue over forehead area
  • not allergic to the patch

You may not qualify if:

  • patients who is not agreed

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

National Taiwan University Hospital

Taipei, 100225, Taiwan

RECRUITING

MeSH Terms

Conditions

Postoperative Complications

Condition Hierarchy (Ancestors)

Pathologic ProcessesPathological Conditions, Signs and Symptoms

Study Officials

  • Feng-Fang Tsai, MD, PhD

    Operation Theater, National Taiwan University Hospital

    PRINCIPAL INVESTIGATOR

Central Study Contacts

Feng-Fang Tsai

CONTACT

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 4, 2020

First Posted

January 26, 2022

Study Start

February 22, 2022

Primary Completion

December 31, 2024

Study Completion

December 31, 2024

Last Updated

January 24, 2024

Record last verified: 2023-02

Locations